» Articles » PMID: 38398195

Novel Prediction Score for Arterial-Esophageal Fistula in Patients with Esophageal Cancer Bleeding: A Multicenter Study

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Feb 24
PMID 38398195
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To develop and internally validate a novel prediction score to predict the occurrence of arterial-esophageal fistula (AEF) in esophageal cancer bleeding.

Methods: This retrospective cohort study enrolled patients with esophageal cancer bleeding in the emergency department. The primary outcome was the diagnosis of AEF. The patients were randomly divided into a derivation group and a validation group. In the derivation stage, a predictive model was developed using logistic regression analysis. Subsequently, internal validation of the model was conducted in the validation cohort during the validation stage to assess its discrimination ability.

Results: A total of 257 patients were enrolled in this study. All participants were randomized to a derivation cohort ( = 155) and a validation cohort ( = 102). AEF occurred in 22 patients (14.2%) in the derivation group and 14 patients (13.7%) in the validation group. A predictive model (HEARTS-Score) comprising five variables (hematemesis, active bleeding, serum creatinine level >1.2 mg/dL, prothrombin time >13 s, and previous stent implantation) was established. The HEARTS-Score demonstrated a high discriminative ability in both the derivation and validation cohorts, with c-statistics of 0.90 (95% CI 0.82-0.98) and 0.82 (95% CI 0.72-0.92), respectively.

Conclusions: By employing this novel prediction score, clinicians can make more objective risk assessments, optimizing diagnostic strategies and tailoring treatment approaches.

References
1.
Lagergren J, Smyth E, Cunningham D, Lagergren P . Oesophageal cancer. Lancet. 2017; 390(10110):2383-2396. DOI: 10.1016/S0140-6736(17)31462-9. View

2.
Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6):649-55. View

3.
Bilal S, Saeed S, Siddique M, Saqib M, Mehmood S, Yusuf M . Salvage therapy of bleeding esophageal tumor by fully covered self-expandable metallic stent: A case report. SAGE Open Med Case Rep. 2021; 9:2050313X21997198. PMC: 7925943. DOI: 10.1177/2050313X21997198. View

4.
Song H, Park S, Do Y, Yoon H, Sung K, Sohn K . Expandable metallic stent placement in patients with benign esophageal strictures: results of long-term follow-up. Radiology. 1997; 203(1):131-6. DOI: 10.1148/radiology.203.1.9122381. View

5.
Monreal M, Falga C, Valdes M, Suarez C, Gabriel F, Tolosa C . Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry. J Thromb Haemost. 2006; 4(9):1950-6. DOI: 10.1111/j.1538-7836.2006.02082.x. View